US Patent 7981922 Angiotensin I-converting enzyme (ACE) inhibitors
Patent 7981922 was granted and assigned to University of Cape Town on July, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+268 characters)
Article
Patent abstract
This invention relates to a process for synthesizing an amino acid derivative of a tripeptidomimetic, such as lisinopril. The invention also relates to a derivative of lisinopril, incorporating a amino acid moeity such as tryptophan at the P2′ position.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Aloysius Nchinda0
Edward Sturrock0
Kelly Chibale0
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07981922 Angiotensin I-converting enzyme (ACE) inhibitors US Patent 7981922 Angiotensin I-converting enzyme (ACE) inhibitors
Infobox
Patent Number
079819220
Patent Number
79819220
Edits on 29 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079819220
Date of Patent
July 19, 2011
0Patent Application Number
119210920
Date Filed
May 29, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07981922 Angiotensin I-converting enzyme (ACE) inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07981922
Date of patent
July 19, 2011
Patent application number
11921092
Date Filed
May 29, 2006
Patent primary examiner
Find more entities like US Patent 7981922 Angiotensin I-converting enzyme (ACE) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.